REGN-7508 is a humanized monoclonal antibody inhibitor targeting FXI. REGN-7508 can be used for atherothrombosis and venous thromboembolism research[1].
Target:
Factor XI
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
